Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 16;15(6):961.
doi: 10.3390/life15060961.

Associations Between Shift Work, Sociodemographic and Lifestyle Characteristics, Body Measurements, and MASLD

Affiliations

Associations Between Shift Work, Sociodemographic and Lifestyle Characteristics, Body Measurements, and MASLD

Javier Tosoratto et al. Life (Basel). .

Abstract

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disorder worldwide and is closely linked to the components of metabolic syndrome. Shift work, through its disruption of circadian rhythms and the promotion of adverse behavioral patterns, has been proposed as a potential contributor to metabolic dysfunction and liver disease, yet evidence on its association with MASLD remains limited in large, heterogeneous occupational populations. Objectives: To investigate the association between shift work and MASLD risk using multiple validated non-invasive indices in a large sample of Spanish workers, and to explore the influence of sociodemographic characteristics, lifestyle behaviors, and sex on these associations. Methods: This cross-sectional study analyzed data from 53,053 employed adults across diverse sectors in Spain, including 31,753 men and 21,300 women. The participants underwent standardized occupational health assessments between 2019 and 2020. The MASLD risk was evaluated using seven indices: fatty liver index (FLI), hepatic steatosis index (HSI), ZJU index, fatty liver disease (FLD) index, Framingham steatosis index (FSI), lipid accumulation product (LAP), and BARD score. Sociodemographic, anthropometric, clinical, biochemical, and lifestyle data were collected. Multinomial logistic regression models were used to assess independent associations between shift work and high-risk MASLD scores. Results: Shift workers exhibited significantly higher mean values and prevalence of elevated MASLD scores across all indices compared to non-shift workers, in both sexes. In men, the prevalence of high BARD scores increased from 43.5% (non-shift) to 71.5% (shift), while in women it rose from 49.9% to 85.7%. Multivariate analysis confirmed that shift work was independently associated with an increased MASLD risk, particularly for HSI (OR: 7.83; 95% CI: 7.40-8.26) and ZJU (OR: 5.91; 95% CI: 5.60-6.22). Male sex, older age, smoking, and blue-collar status were also consistently associated with elevated risk scores. Conclusions: Shift work is significantly associated with an increased MASLD risk, independent of sociodemographic and lifestyle factors. Women and blue-collar workers may be especially vulnerable to the hepatic consequences of circadian disruption. These findings support the inclusion of liver health screening in occupational health programs and highlight the need for targeted interventions to reduce the MASLD risk among shift-working populations. Cross-sectional design limits causality; longitudinal studies are needed to confirm temporal relationships.

Keywords: MASLD; lifestyle habits; liver indices; metabolic health; shift work; sociodemographic factors.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest.

Figures

Figure 1
Figure 1
Flowchart of the participants.

Similar articles

References

    1. Koshy A. Evolving Global Etiology of Hepatocellular Carcinoma (HCC): Insights and Trends for 2024. J. Clin. Exp. Hepatol. 2025;15:102406. doi: 10.1016/j.jceh.2024.102406. - DOI - PMC - PubMed
    1. Younossi Z.M., Wong G., Anstee Q.M., Henry L. The Global Burden of Liver Disease. Clin. Gastroenterol. Hepatol. 2023;21:1978–1991. doi: 10.1016/j.cgh.2023.04.015. Erratum in BMC Cardiovasc Disord. 2006, 6, 5. - DOI - PubMed
    1. Boccatonda A., Andreetto L., D’ardes D., Cocco G., Rossi I., Vicari S., Schiavone C., Cipollone F., Guagnano M.T. From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications. Biomedicines. 2023;11:883. doi: 10.3390/biomedicines11030883. - DOI - PMC - PubMed
    1. Han S.K., Baik S.K., Kim M.Y. Non-alcoholic fatty liver disease: Definition and subtypes. Clin. Mol. Hepatol. 2023;29((Suppl.)):S5–S16. doi: 10.3350/cmh.2022.0424. - DOI - PMC - PubMed
    1. Friedman S.L., Pinzani M. Hepatic fibrosis 2022: Unmet needs and a blueprint for the future. Hepatology. 2022;75:473–488. doi: 10.1002/hep.32285. - DOI - PMC - PubMed

LinkOut - more resources